Skip to content

Dexcom Inc.

DXCM pitch short Marc Grow ’17, Benjamin Ostrow ’17, and Evan Zehnal ’17

Thesis

Dexcom Inc. is facing significant challenges in its market position and competitive landscape, which could lead to a decline in its stock price. The company's growth may not sustain at the current levels due to increasing competition and pricing pressures.

Did it work?

inconclusive confidence: low

The pitch is a short on Dexcom based on a generic thesis of intensifying competition and pricing pressure eroding growth, but no price performance and no elapsed time are provided. Without either a return figure or evidence that the competitive/pricing dynamics actually materialized and pressured results, there is nothing to confirm or invalidate the thesis. A verdict of worked or failed cannot be supported on this record.